Free Trial
NASDAQ:MTEM

Molecular Templates (MTEM) Stock Price, News & Analysis

Molecular Templates logo

About Molecular Templates Stock (NASDAQ:MTEM)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
5.40 million shs
Market Capitalization
$1 thousand
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MTEM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Molecular Templates and its competitors with MarketBeat's FREE daily newsletter.

MTEM Stock News Headlines

Nasdaq to file Form 25-NSE with SEC to delist Molecular Templates
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump could be just weeks away. And it holds the potential to trigger one of the most explosive tech booms in US history. At the center of it all? Robots. Not the kind that clean your house or pour you coffee. But the kind that could reshape entire industries, add $1.2 trillion per year to the US economy, and affect 65 million American lives — just in the next year.
Molecular Templates Announces Key Leadership Transition
See More Headlines

MTEM Stock Analysis - Frequently Asked Questions

Molecular Templates, Inc. (NASDAQ:MTEM) posted its quarterly earnings results on Monday, November, 15th. The biotechnology company reported ($8.10) earnings per share for the quarter, missing the consensus estimate of ($5.67) by $2.43. The biotechnology company earned $2.38 million during the quarter, compared to analysts' expectations of $15.69 million. Molecular Templates had a negative trailing twelve-month return on equity of 260.50% and a negative net margin of 61.35%.

Shares of Molecular Templates reverse split before market open on Monday, August 14th 2023.The 1-15 reverse split was announced on Friday, August 11th 2023. The number of shares owned by shareholders was adjusted after the market closes on Friday, August 11th 2023. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

Shares of MTEM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Molecular Templates investors own include NVIDIA (NVDA), Meta Platforms (META), GE Aerospace (GE), Advanced Micro Devices (AMD), CymaBay Therapeutics (CBAY), Alibaba Group (BABA) and Catalyst Pharmaceuticals (CPRX).

Company Calendar

Last Earnings
11/15/2021
Today
7/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:MTEM
CIK
1183765
Employees
260
Year Founded
2009

Profitability

EPS (Trailing Twelve Months)
($2.70)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$8.12 million
Net Margins
-61.35%
Pretax Margin
-61.39%
Return on Equity
-260.50%
Return on Assets
-46.90%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.56
Quick Ratio
1.56

Sales & Book Value

Annual Sales
$23.48 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.78 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
6,584,000
Free Float
5,669,000
Market Cap
$1 thousand
Optionable
No Data
Beta
1.53

Social Links

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (NASDAQ:MTEM) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners